CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Cyclin A/B-RxL Inhibitor CID-078 in Patients With Advanced Solid Tumor Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06577987
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:19.090549+00:00
Published At: 2025-09-15T00:00:00+00:00
Record Updated At: 2025-09-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Solid Tumor", "Metastatic Solid Tumor", "Refractory Solid Tumor", "Cancer", "Lung Cancer", "Triple Negative Breast Cancer", "Breast Neoplasms", "Neuroendocrine Tumors", "Neuroendocrine Carcinoma", "RB1 Gene Mutation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-15"
protocolSection.identificationModule.nctId: "NCT06577987"
protocolSection.identificationModule.officialTitle: "A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Cyclin A/B-RxL Inhibitor CID-078 in Patients With Advanced Solid Tumor Malignancies"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.